Whalerock Point Partners LLC cut its stake in shares of Monsanto Company (NYSE:MON) by 15.1% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,905 shares of the basic materials company’s stock after selling 875 shares during the quarter. Whalerock Point Partners LLC’s holdings in Monsanto were worth $580,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Pinnacle Financial Partners Inc. acquired a new position in shares of Monsanto during the 2nd quarter worth $114,000. Acrospire Investment Management LLC purchased a new stake in shares of Monsanto in the 1st quarter worth about $113,000. Armbruster Capital Management Inc. boosted its position in shares of Monsanto by 12.2% in the 2nd quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock worth $136,000 after buying an additional 125 shares in the last quarter. JNBA Financial Advisors boosted its position in shares of Monsanto by 3.9% in the 1st quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock worth $135,000 after buying an additional 45 shares in the last quarter. Finally, Penserra Capital Management LLC boosted its position in shares of Monsanto by 9.5% in the 1st quarter. Penserra Capital Management LLC now owns 1,288 shares of the basic materials company’s stock worth $145,000 after buying an additional 112 shares in the last quarter. 74.79% of the stock is currently owned by institutional investors and hedge funds.
In related news, EVP Robert T. Fraley sold 52,410 shares of the business’s stock in a transaction that occurred on Monday, July 10th. The stock was sold at an average price of $117.95, for a total value of $6,181,759.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Steven Mizell sold 11,300 shares of the business’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total value of $1,339,841.00. Following the completion of the sale, the executive vice president now owns 55,011 shares of the company’s stock, valued at $6,522,654.27. The disclosure for this sale can be found here. 0.79% of the stock is currently owned by insiders.
Shares of Monsanto Company (MON) traded up 0.57% during mid-day trading on Friday, reaching $118.27. 2,233,896 shares of the company’s stock traded hands. The firm has a 50-day moving average price of $117.25 and a 200-day moving average price of $116.44. Monsanto Company has a 1-year low of $97.35 and a 1-year high of $118.97. The company has a market capitalization of $51.96 billion, a P/E ratio of 25.54 and a beta of 1.07.
Monsanto (NYSE:MON) last posted its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The firm had revenue of $4.23 billion during the quarter, compared to analyst estimates of $4.18 billion. During the same period in the previous year, the company earned $2.17 EPS. The company’s revenue for the quarter was up 1.0% on a year-over-year basis. On average, equities research analysts forecast that Monsanto Company will post $4.89 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be issued a $0.54 dividend. The ex-dividend date is Thursday, October 5th. This represents a $2.16 annualized dividend and a yield of 1.83%. Monsanto’s dividend payout ratio (DPR) is currently 46.75%.
Several equities research analysts recently commented on MON shares. Zacks Investment Research upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $131.00 price objective on the stock in a research report on Monday, September 4th. BMO Capital Markets reiterated a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a research report on Friday, September 1st. BidaskClub lowered shares of Monsanto from a “hold” rating to a “sell” rating in a research report on Sunday, July 16th. Vetr upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price objective on the stock in a research report on Wednesday, July 12th. Finally, Susquehanna Bancshares Inc reiterated a “neutral” rating and issued a $128.00 price objective (up from $125.00) on shares of Monsanto in a research report on Tuesday, June 27th. Ten equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $124.09.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.